Tiagabine Hydrochloride
Active substance: tiagabine
TABLET, FILM COATED · TIAGABINE HYDROCHLORIDE 2 mg/1
United StatesActive
Marketing holder: Teva Pharmaceuticals USA, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TIAGABINE HYDROCHLORIDE · 2 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4ccb-7ca8-a29a-40691f01d4a3,01a1208c-8b3b-737b-a67d-2531aa82d7bf,01a1208f-9422-7494-926e-53b28a23a19c,01a12092-a72d-736c-a20a-18b3283c9551,01a12092-a736-79ac-b47e-5293436b5a30;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0093-5030
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0093-5030 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0093-5030 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0093-5030 · Verified 2026-10-09 · open in source